JAMES ISERNIA: Open Payments
NPI 1144281148 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,674 in 83 payments from 23 companies in 2025. Trend: 2023 $1,601 · 2024 $6,600 · 2025 $1,674
Food & beverage: $1,674
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $356 |
| UCB, Inc. | 13 | $275 |
| Amgen Inc. | 15 | $166 |
| Radius Health, Inc. | 6 | $113 |
| Janssen Biotech, Inc. | 6 | $112 |
| SANOFI-AVENTIS U.S. LLC | 4 | $69 |
| BETA BIONICS, INC. | 2 | $66 |
| Mallinckrodt Hospital Products Inc. | 2 | $57 |
| Madrigal Pharmaceuticals | 1 | $44 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
Products named: Bimzelx, Ozempic, Wegovy, Tymlos, TREMFYA, EVENITY, TZIELD, iLet Bionic Pancreas.
Industry payments across SC — which companies pay providers there.
